BMT-145027 inhibits the signaling pathway between G-protein-coupled receptors (GPCRs) and G proteins. It targets mGluR5.
Molecular Weight
438.83
Molecular Formula
C23H14ClF3N4
Targets
mGluR5: 47 nM (EC50)
Form
Lyophilized powder
Purity
>98%
Applications
BMT-145027 can be used to research and develop therapeutic strategies for certain diseases that involve excessive activation of GPCR-G protein signaling pathways.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
